Navigation Links
NewCardio Announces Financial Results for Its 2010 Third Quarter
Date:11/15/2010

SANTA CLARA, Calif., Nov. 15, 2010 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced financial results for the third quarter and nine months ended September 30, 2010. More details on the financial results are available in the SEC Form 10-Q, filed today with the Securities and Exchange Commission.

"We continue to make progress in the commercialization of our initial solution, QTinno™, and in securing the strategic funding which will accelerate the development and commercialization of our 3-D platform technology solutions, including CardioBip™, the emerging opportunity in telemedicine with remote patient monitoring – and my3KG™ - whose first deployment is expected to be in the emergency room," commented Vincent Renz, NewCardio's President and CEO. "We are gaining visibility to  a growing number of  Phase 1 QT studies, from both current and prospective customers, and we remain optimistic regarding acceleration of revenues due to pent-up demand for these studies as the economy, and with it, the market, improve. Our initiative to identify a strategic funding partner also continues to move forward, and I am encouraged by the progress to date and continue to believe we are on the right path towards securing strategic funding to support our development and commercialization activities."

Highlights

  • Pharma Lynx, a global contract research organization and a subsidiary of Diverse Lynx, has signed an MSA to license NewCardio's QTinno solution for use in Phase 1 studies. To date, the Company has 7 MSAs, including three of the top five Contract Research Organizations (CROs) in the world, and QTinno has been selected by two pharmaceutical companies as the preferred solution for automated QT studies.
  • The Company bolstered its position with industry l
    '/>"/>

  • SOURCE NewCardio, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. NewCardio Announces Positive Results From Third Clinical Validation Study
    2. Vincent W. Renz Joins NewCardio as President
    3. NewCardio Leadership to Present Two Abstracts at ISCE Conference
    4. NewCardio Announces Master Services Agreement With Dedicated Phase I
    5. NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
    6. NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress
    7. NewCardio CEO Increases Equity Position
    8. NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded Testing Dataset
    9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... -- CVS Health Corporation (NYSE: CVS ) will ... 2015, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will be ... CVS Health website for all interested parties. To access ... be archived and available on the web site for ...
    (Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has ... Global Strategic Business Report" report to their offering. ... ADME-Toxicology Testing in US$ Million by the following Segments: ... The report provides separate comprehensive analytics for the ... , Europe , ...
    (Date:4/17/2015)... 2015  Trovagene, Inc., (NASDAQ:  TROV) a developer ... data presented at the 2015 European Lung Cancer ... Monitoring ℠ (PCM) platform outperformed tissue biopsy ... T790M mutations in metastatic lung cancer patients. ... Mutation in Urinary Circulating Tumor DNA from Metastatic ...
    Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
    ... Mass., Nov. 24 Echo Therapeutics, Inc. (OTC Bulletin ... System as a non-invasive, wireless, transdermal continuous glucose monitoring ... drug delivery, announced today that Patrick T. Mooney, M.D., ... 13th Annual Biotech and Specialty Pharmaceuticals Conference, sponsored by ...
    ... , NORTH HOLLYWOOD, Calif., Nov. 24 IPC The Hospitalist Company, ... practice company, announced today that Philip Vaidyan, M.D., FACP, an IPC ... the 2009 Top Ten Hospitalists in the nation. He was recognized ... has been a practicing physician for more than 10 years and ...
    Cached Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
    (Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will ... 2015. The event will be held in the heart of ... Ave NW, Grand Rapids, MI 49503) and will feature wine ... Patrons are encouraged to savor the food and beverage pairings ... year’s event will feature seven chefs, including:, ...
    (Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
    (Date:4/17/2015)... 17, 2015 Calvary Hospital recently announced Timothy ... Executive Vice President on May 11. The Fund directs all ... mission. Barr succeeds Vincent J. Spinelli, who retired several months ... take on and supervise the important work that the Fund ... “As Calvary continues to expand and bring our signature care ...
    (Date:4/17/2015)... Nomedexamlifeinsurance.com has released a new blog post explaining how ... , Smoking is linked to numerous diseases like cancer ... smokers more money for life insurance plans. Someone who ... can qualify for advantageous offers. , The life ... non-smokers. Comparing quotes is the best method of reducing ...
    (Date:4/17/2015)... Verndale, a Global Experience Technology Company, ... been chosen as a Boston Business Journal (BBJ) Pacesetter, ... the region. The BBJ’s Pacesetters represents privately held businesses ... 2014. This is the eighth consecutive year and the ... has been honored with this award. , “Being honored ...
    Breaking Medicine News(10 mins):Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Life Insurance Quotes for Smokers Available Online 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
    ... BioFit Engineered Products, an Ohio-based manufacturer and long-standing leader in ... and Atmospheric Administration (NOAA) with a solution to a unique ... habitat. , ... Bowling Green, OH ...
    ... expansion of its Sealy office. , ... Sealy, Texas (PRWEB) January 8, ... Sealy office. Located on Meyer Street the five-year old-practice has blossomed reaching ... of the surrounding communities as well., , , , ,The eye ...
    ... Service Employees,International Union (SEIU) announced the formation of the ... the patients that they serve,a greater voice as we ... nation,s,history. , Since adoption of ... made,numerous jurisdiction decisions that have helped members who do ...
    ... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" ... and personal care products company announced that on January ... stock repurchase fund according to the terms approved by ... up to Ps. 100 million pesos. Company Description ...
    ... EXTON, Pa., Jan. 9 Kensey Nash Corporation (Nasdaq: ... release its earnings results for its second quarter ended ... Wednesday, January 28, 2009. Joe Kaufmann, President and ... results on Wednesday, January 28, 2009 at 9:00 A.M. ...
    ... study found, , , FRIDAY, Jan. 9 (HealthDay News) -- If ... cut your risk of dying from flu in half, research ... perfect match for the strains circulating in any given year, ... that included 10 flu seasons, worth of data also found ...
    Cached Medicine News:Health News:BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Statement From SEIU International President Andy Stern on UHW Leaders' Response to the Jurisdiction Decision 2Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: